Ying Li

42PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Horticultural crop improvement (incl. selection and breeding)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Aug 11, 2026
PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.

|Jul 28, 2026
Lactococcal Extracellular Vesicles as In Situ Vaccine Activators in Combination with Doxorubicin for Cancer Therapy.

|Jun 12, 2026
Chickpea (Cicer arietinum L.): Integrating Nutritional Excellence, Health Benefits, and Abiotic Stress Resilience for Sustainable Food Systems.

|May 18, 2026
PMN-MDSCs-derived exosomal S100A9 drives breast cancer progression by enhancing cancer stemness and CXCL5-mediated metastatic potential.

|Feb 27, 2026
Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation.

Peng Liu, Zhe Zhou, Xiaoqiu Su

|Jan 28, 2026
Terpenoids: Emerging Natural Modulators for Reversing ABC Transporter-Mediated Multidrug Resistance in Cancer Chemotherapy.

Lanfei Ma, Dina Mahemuti, Yuanhong Lan

Pageof 7

Frequent Collaborators

11 joint publications

Zhongxiong Fan

6 joint publications

Lijie Xia

5 joint publications

Yuekang Xu

4 joint publications

Yuan Li